This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Lalit Kumar Khurana: Innovator in Pharmaceutical Dosage Forms
Introduction
Lalit Kumar Khurana is a notable inventor based in Chandigarh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the efficacy and delivery of medications.
Latest Patents
Khurana holds a patent for a pharmaceutical gastro-retentive solid oral dosage form of nilotinib. This invention relates to a dosage form that comprises nilotinib as the active ingredient. The patent also includes methods for preparing this gastro-retentive dosage form, which aims to enhance the therapeutic effects of nilotinib.
Career Highlights
Khurana is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create advanced pharmaceutical solutions.
Collaborations
Some of his coworkers include Anuj Kumar Fanda and Ravish Sharma, who contribute to the innovative environment at Sun Pharmaceutical Industries Limited.
Conclusion
Lalit Kumar Khurana's work in pharmaceutical innovations exemplifies the importance of research in enhancing drug delivery systems. His contributions are paving the way for more effective treatments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile